The Anthropic Assets division applies biologically informed engineering and human–machine collaboration to support general wellbeing, recovery, and adaptability. Its work is grounded in controlled research programs that prioritise humans first, with a focus on technological integration, support systems, and aspects of health such as metabolism, recovery, and physical resilience, supported through precision formulation and system design.

Key initiatives include nutrient delivery systems, recovery support methods, and physiological support technologies, complemented by Companion Intelligence - an AI framework that enables adaptive learning and personalised support insights within defined use contexts.

Nutritional products such as Body Matrix protein, and separately in vitro diagnostic reagents (including CorrecTin VL, Kaolin Clotting Time, and Detectin VL), serve as reference points. The diagnostic reagents are intended for laboratory use in identifying phospholipid-dependent clotting abnormalities associated with lupus anticoagulants, in accordance with applicable clinical standards.